Fact CheckerSign in

NCT05301907Completed

Survey Among Healthcare Professionals and MS Patients to Assess Their Understanding of RMP Materials

Survey Among Healthcare Professionals and MS Patients/Caregivers in Selected European Countries to Evaluate the Knowledge Required for the Safe Use of Mayzent

Source: ClinicalTrials.gov · Last updated 24 Dec 2025

Brief summary (registry, in English)

Survey to be completed independently by HCPs (neurologists treating patients with MS and MS specialist nurses) and patients/caregivers.

Status (registry)
Completed
Study type
Observational
Enrollment
335 (actual)
First submitted
21 Mar 2022
Start date
2 Dec 2021
Primary completion date
16 May 2025
Lead sponsor
Novartis Pharmaceuticals
NCT number
NCT05301907

What you commit to

  • Study type: Observational
  • Participants enrolled: 335
  • From 2 Dec 2021 to the primary completion date, 16 May 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • \-

Who the study is looking for

  • Physicians were considered eligible for the survey if they meet the following screening criteria:
  • Care for relapsing MS (RMS) patients
  • Personally prescribed disease modifying therapies to MS patients, and;
  • Have prescribed Mayzent (siponimod) in at least 1 SPMS patient.
    • Nurses were considered eligible for the survey if they:
  • Provide supportive care for RMS patients
  • Have initiated and/or managed the use of Mayzent (siponimod) in at least 1 SPMS patient.
    • Patient inclusion criteria include:
    • \- Had initiated onto Mayzent (siponimod) to treat their MS since reimbursement

Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
-
Coordinator of this site? Confirm its status
BaselSwitzerlandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.